These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 23082830)
21. Medication Adherence in Patients Undergoing Methadone Maintenance Treatment in Xi'an, China. Zhou K; Li H; Wei X; Li X; Zhuang G J Addict Med; 2017; 11(1):28-33. PubMed ID: 27649264 [TBL] [Abstract][Full Text] [Related]
22. Effect of traumatic event reexposure and PTSD on substance use disorder treatment response. Peirce JM; Brooner RK; King VL; Kidorf MS Drug Alcohol Depend; 2016 Jan; 158():126-31. PubMed ID: 26652898 [TBL] [Abstract][Full Text] [Related]
23. The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study. Dennis BB; Akhtar D; Cholankeril G; Kim D; Sanger N; Hillmer A; Chawar C; D'Elia A; Panesar B; Worster A; Marsh DC; Thabane L; Samaan Z; Ahmed A Drug Alcohol Depend; 2020 Apr; 209():107917. PubMed ID: 32088589 [TBL] [Abstract][Full Text] [Related]
24. Childhood sexual abuse, post-traumatic stress disorder, and use of heroin among female clients in Israeli methadone maintenance treatment programs (MMTPS). Schiff M; Levit S; Cohen-Moreno R Soc Work Health Care; 2010; 49(9):799-813. PubMed ID: 20938876 [TBL] [Abstract][Full Text] [Related]
25. Psychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenance. Jaremko KM; Sterling RC; Van Bockstaele EJ J Subst Abuse Treat; 2015 Jan; 48(1):117-27. PubMed ID: 25239858 [TBL] [Abstract][Full Text] [Related]
26. Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use. Socías ME; Wood E; Small W; Dong H; Shoveller J; Kerr T; Montaner J; Milloy MJ Drug Alcohol Depend; 2016 Nov; 168():211-218. PubMed ID: 27701042 [TBL] [Abstract][Full Text] [Related]
27. Loneliness and Illicit Opioid Use Among Methadone Maintenance Treatment Patients. Polenick CA; Cotton BP; Bryson WC; Birditt KS Subst Use Misuse; 2019; 54(13):2089-2098. PubMed ID: 31232142 [No Abstract] [Full Text] [Related]
28. Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China. Yin W; Pang L; Cao X; McGoogan JM; Liu M; Zhang C; Li Z; Li J; Rou K Addiction; 2015 Jan; 110 Suppl 1():51-60. PubMed ID: 25533864 [TBL] [Abstract][Full Text] [Related]
29. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386 [TBL] [Abstract][Full Text] [Related]
30. Posttraumatic stress disorder and short-term outcome in early methadone treatment. Hien DA; Nunes E; Levin FR; Fraser D J Subst Abuse Treat; 2000 Jul; 19(1):31-7. PubMed ID: 10867298 [TBL] [Abstract][Full Text] [Related]
31. Opioid substitution treatment reduces substance use equivalently in patients with and without posttraumatic stress disorder. Trafton JA; Minkel J; Humphreys K J Stud Alcohol; 2006 Mar; 67(2):228-35. PubMed ID: 16562404 [TBL] [Abstract][Full Text] [Related]
32. Treatment non-adherence among methadone maintenance patients and associated factors: a multicenter, cross-sectional study in Vietnam. Nguyen HTT; Dinh DX Harm Reduct J; 2024 Jul; 21(1):129. PubMed ID: 38961458 [TBL] [Abstract][Full Text] [Related]
33. Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016. Socías ME; Wood E; Kerr T; Nolan S; Hayashi K; Nosova E; Montaner J; Milloy MJ Drug Alcohol Depend; 2018 Aug; 189():90-95. PubMed ID: 29894910 [TBL] [Abstract][Full Text] [Related]
35. Characteristics and current clinical practices of opioid treatment programs in the United States. Jones CM; Byrd DJ; Clarke TJ; Campbell TB; Ohuoha C; McCance-Katz EF Drug Alcohol Depend; 2019 Dec; 205():107616. PubMed ID: 31678836 [TBL] [Abstract][Full Text] [Related]
36. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users. Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438 [TBL] [Abstract][Full Text] [Related]
37. Outcome of Patients With High Depressive Symptoms on Admission to Methadone Maintenance Treatment. Malik E; Adelson M; Sason A; Schreiber S; Peles E J Dual Diagn; 2019; 15(4):281-290. PubMed ID: 31530109 [No Abstract] [Full Text] [Related]
38. Predictors of non-adherence to methadone maintenance treatment in opioid-dependent individuals: implications for clinicians. Roux P; Lions C; Michel L; Cohen J; Mora M; Marcellin F; Spire B; Morel A; Carrieri PM; Karila L; Curr Pharm Des; 2014; 20(25):4097-105. PubMed ID: 24001291 [TBL] [Abstract][Full Text] [Related]
39. Impact of lifetime psychiatric diagnosis on long-term retention and survival of former opiate addicts in methadone maintenance treatment. Peles E; Schreiber S; Domany Y; Adelson M World J Biol Psychiatry; 2014 Dec; 15(8):629-35. PubMed ID: 25140586 [TBL] [Abstract][Full Text] [Related]
40. Utilization of buprenorphine and methadone among opioid users who inject drugs. Tsui JI; Burt R; Thiede H; Glick SN Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]